In a significant breakthrough for regenerative medicine and oncology, researchers at the University of Basel and University Hospital Basel have…
Read More
Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.
A federal jury in Dallas has delivered a decisive verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…
Read More
CMS Launches Sweeping Anti-Fraud Initiative, Targeting Genetic Testing Spending and Soliciting Lab Industry Input for Future Regulations
The Centers for Medicare and Medicaid Services (CMS) has embarked on a significant preemptive strike against healthcare fraud, initiating a…
Read More
Ex-NFL Player Convicted in $328M Genetic Testing Fraud as Medicare Scrutiny Intensifies
A federal jury in Dallas has delivered a resounding verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…
Read More
Donor-Derived Cell-Free DNA Testing Revolutionizes Post-Transplant Surveillance, Offering Early Organ Injury Detection and Reducing Invasive Biopsies
A groundbreaking blood test measuring donor-derived cell-free DNA (dd-cfDNA) is fundamentally transforming post-transplant patient management, providing clinical laboratories with an…
Read More
Researchers Create First Fully Human 3D Bone Marrow Model to Advance Cancer Treatment and Reduce Animal Testing
In a landmark development for regenerative medicine and oncology, scientists at the University of Basel and University Hospital Basel have…
Read MoreYOU MAY HAVE MISSED
